St. Louis Children's Hospital

APPCN MEMBER SINCE 2010

Department of Psychology
Post-Doctoral Residency in Pediatric Neuropsychology

Co-Directors: Suzanne Pierson, Ph.D., ABPP-CN & Jonathan Dodd, Psy.D., ABPP-CN
Department of Psychology
1 Children’s Place, Suite 3N-14
St. Louis, MO 63110

Telephone: 314-454-6069
Fax: 314-454-4013

Email: Suzanne.Pierson@bjc.org or Jonathan.Dodd@bjc.org
Website: http://www.stlouischildrens.org/sites/default/files/services/psychology_services/files/SLCH%20Program%20Description%202018-2020.pdf

2018 application deadline: January 2, 2018

2018 residency start date: September 4, 2018

Program will do interviews at INS in 2018: Yes

Policy regarding on-site interviews: Applicants who are not attending INS may arrange to interview on-site prior to INS. Options for interviews via Skype may also be available. 

Clinical neuropsychology residency openings for 2018: 1
Clinical neuropsychology residency positions: 1 (we will accept a new resident every other year)
Residency/fellowship positions in psychology: 3 (2 pediatric psychology fellow, 1 neuropsychology fellow)

Clinical neuropsychologists: 5 Full-time; 1 part-time; 0 consultants
With ABCN/ABPP: 2 Full-time (1 in process); 0 part-time; 0 consultants

Other psychologists: 8 Full-time; 2 part-time; 0 consultants
With ABPP: 1 Full-time; 0 part-time; 0 consultants

Graduate training of residency applicants:

Preferred: clinical psychology, clinical neuropsychology, school psychology
Accepted: counseling psychology, health psychology

Primary emphasis: Pediatric

Emphases of training opportunities:

Strong: neuropsychological assessment and consultation, multidisciplinary teams
Medium: research
Weak: psychotherapy, forensics, rehabilitation

Availability of patient populations:

Strong: epilepsy, neuro-oncology, hematology-oncology (pre- and post-bone marrow transplant, late effects, sickle cell disease), concussion/traumatic brain injury, hydrocephalus, general outpatient neurology
Moderate: cerebral palsy/perinatal stroke, solid organ transplant, genetics (emphasis on neurofibromatosis type 1)
Weak: autism/pervasive developmental disorders, ADHD/learning disability, psychiatric symptoms as the primary concern

 

updated 11/16/2017